Gene · 23135
Papers3,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic and metabolic reprogramming support plasma cell differentiation in germinal centers. | J Exp Med | 2026 | 41604248 | PubTator, text mining | PubMed |
| Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment. | Exp Hematol Oncol | 2026 | 41588554 | PubTator, text mining | PubMed |
| Meeting Review on India EMBO lecture course on RNA-protein complexes: from molecular assembly to physiological functions and disease. | Biol Open | 2026 | 41582833 | PubTator, text mining | PubMed |
| Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications. | Signal Transduct Target Ther | 2026 | 41582215 | PubTator, text mining | PubMed |
| JMJD3 and UTX as key targets for gene-modified mesenchymal stem cell therapy in cartilage tissue engineering. | Mol Ther | 2026 | 41566779 | PubTator, text mining | PubMed |
| ELK1 promotes the progress of myeloid leukemia by hindering the differentiation of neutrophils. | Exp Hematol Oncol | 2026 | 41559783 | PubTator, text mining | PubMed |
| H3K27-specific demethylase orchestrates the phenotypic and functional plasticity of intestinal ILC3s. | Cell Rep | 2026 | 41557504 | PubTator, text mining | PubMed |
| Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML. | Hemasphere | 2026 | 41551728 | PubTator, text mining | PubMed |
| New autoantibodies in Sjögren's disease. | Curr Opin Immunol | 2026 | 41534451 | PubTator, text mining | PubMed |
| Skin tape strips identify age-specific immune, metabolic, and barrier dysregulation signatures in children, adolescents, and adults with allergic asthma. | J Allergy Clin Immunol | 2026 | 41506478 | PubTator, text mining | PubMed |
| Design and synthesis of novel quinazoline derivatives as KDM6B selective inhibitors. | Mol Divers | 2026 | 41417192 | PubTator, text mining | PubMed |
| The KDM6B/SLC10A2 Axis Suppresses MDSCs Recruitment via ERK/AP-1 Signaling in Colorectal Cancer. | Adv Sci (Weinh) | 2026 | 41387297 | PubTator, text mining | PubMed |
| Stimulator of interferon genes: A potential target for treating type 2 diabetes mellitus. | Biochem Pharmacol | 2026 | 41161546 | PubTator, text mining | PubMed |
| Peritoneal cavity-derived GATA6+ macrophages inhibit fibrosis through IL33 in endometrium. | J Adv Res | 2026 | 40592367 | PubTator, text mining | PubMed |
| Exploring the genetic characteristics of overweight-related osteoarthritis using machine learning. | Comput Methods Biomech Biomed Engin | 2026 | 40436638 | PubTator, text mining | PubMed |
| Biological Interplay between Orthodontic Forces and Apical Papilla-derived Stem Cells: A Review on Mechanisms and Implications :. | Galen Med J | 2025 | 42038179 | PubTator, text mining | PubMed |
| Cerium oxide nanoparticles for enhanced healing of diabetic foot ulcers. | Front Bioeng Biotechnol | 2025 | 41602470 | PubTator, text mining | PubMed |
| Identification of key genes related to metabolic cell death in hepatic ischemia-reperfusion injury from transcriptome data and mechanism research using single-cell data. | Front Immunol | 2025 | 41550926 | PubTator, text mining | PubMed |
| [Key genes of intervertebral disc degeneration with ferroptosis and prediction of potential traditional Chinese medicine based on bioinformatics and machine learning]. | Zhongguo Zhong Yao Za Zhi | 2025 | 41508240 | PubTator, text mining | PubMed |
| Anti-tumor effects and mechanism of the histone demethylase inhibitor GSK-J4 in non-small cell lung cancer cells. | Med Oncol | 2025 | 41452395 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23135/papers?page=5